Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Mitglied/er, Innere Klinik (Tumorforschung)
Aktuelle Veranstaltungen
Vergangene Veranstaltungen (max. 10)
-
SoSe 2025
-
WiSe 2024
-
SoSe 2024
-
WiSe 2023
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Comparison of Palliative Knowledge and Self-Efficacy Expectation of German Paramedics Between a Rural and an Urban Structured Emergency Medical Service AreaIn: Journal of Palliative Care (JPC), Jg. 40, 2025, Nr. 4, S. 329 – 335DOI (Open Access)
-
Neue Technologien in Forschung und Palliativversorgung : Die Wissenschaftlichen Arbeitstage der DGP 2024In: Zeitschrift für Palliativmedizin, Jg. 26, 2025, Nr. 5, S. 258 – 264
-
Neurofeedback Reduces P300 Amplitudes to Intensely Emotive Pictures in Depressed Cancer PatientsIn: Clinical EEG and Neuroscience, Jg. 56, 2025, Nr. 3, S. 217 – 229DOI (Open Access)
-
Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting : Rationale and design of the EMPATICC trialIn: European Journal of Heart Failure, Jg. 27, 2025, Nr. 10, S. 1905 – 1917DOI (Open Access)
-
Resistance training in cachectic pancreatic and lung cancer patients : randomised controlled trialIn: BMJ Supportive & Palliative Care, 2025, in press
-
Validation of the Palliative Care and Rapid Emergency Screening (P-CaRES) Tool in GermanyIn: Journal of Clinical Medicine (JCM), Jg. 14, 2025, Nr. 7, 2191DOI (Open Access)
-
Applicability of a digital health application for cancer patients : A qualitative non-participation analysisIn: BMC Health Services Research, Jg. 24, 2024, Nr. 1, 1187DOI, Online Volltext (Open Access)
-
Determining the cut-off value for the Minimal Documentation System (MIDOS2) screening tool to initiate specialized palliative care based on patient’s subjective need for palliative support and symptom burden in inpatients with advanced cancerIn: Journal of Cancer Research and Clinical Oncology, Jg. 150, 2024, Nr. 7, 360DOI, Online Volltext (Open Access)
-
Differential effects of mindfulness treatment and mobile neurofeedback on event-related potentials in early posterior negativity in cancer patients : A clinical-experimental parallel group designIn: Frontiers in Psychology, Jg. 15, 2024, 1395032DOI, Online Volltext (Open Access)
-
Drivers and barriers of patients’ acceptance of video consultation in cancer careIn: Digital Health, Jg. 10, 2024DOI, Online Volltext (Open Access)
-
Entwicklung digitaler Screeningprozesse für eine konsentierte multiprofessionelle Behandlung am Westdeutschen Tumorzentrum Essen : Multiprofessionelles Supportivscreening in der Routine mit Patient-Reported Outcome Measures (PROM) – Best PracticeIn: Die Onkologie, Jg. 30, 2024, Nr. 8, S. 721 – 728
-
Erfassung existenzieller und spiritueller Bedürfnisse bei Patient*innen in der Palliativsprechstunde mit dem Spiritual Needs Screener : Befunde und Reaktionen des PalliativteamsIn: Zeitschrift für Palliativmedizin, 2024
-
Investigation of screening questions to identify insomnia in cancer patientsIn: Scientific Reports, Jg. 14, 2024, Nr. 1, 18343DOI, Online Volltext (Open Access)
-
Machine Learning-Based Prediction of 1-Year Survival Using Subjective and Objective Parameters in Patients With CancerIn: JCO Clinical Cancer Informatics (JCO CCI), Jg. 8, 2024, e2400041
-
Multicenter exploration of specialist palliative care in patients with left ventricular assist devices : a retrospective studyIn: BMC Palliative Care, Jg. 23, 2024, Nr. 1, 229DOI (Open Access)
-
P-move : A randomized control trial of exercise in patients with advanced pancreatic or biliary tract cancer (aPBC) receiving beyond first-line chemotherapyIn: Supportive Care in Cancer, Jg. 32, 2024, Nr. 7, 437DOI (Open Access)
-
Relevance of Patient-Reported Outcome Measures in Patients with Cancer : Detection of Underrated Psychological Distress of Palliative Care Patients in an Outpatient SettingIn: Palliative Medicine Reports, Jg. 5, 2024, Nr. 1, S. 194 – 200DOI, Online Volltext (Open Access)
-
Screening auf Bedarf an spezialisierter Palliativversorgung : Know-how und ScreeningtoolsIn: Die Onkologie, Jg. 30, 2024, Nr. 9, S. 850 – 856
-
Symptom burden and relief in palliative care units of German Comprehensive Cancer Center and other hospitalsIn: Journal of Cancer Research and Clinical Oncology, Jg. 150, 2024, Nr. 3, 160DOI (Open Access)
-
The novel manualized RELIEVE-group treatment for burdened relatives of cancer patients : A feasibility studyIn: Frontiers in Psychology, Jg. 15, 2024, 1492219DOI, Online Volltext (Open Access)
-
Cancer Patients’ Age-Related Benefits from Mobile Neurofeedback-Therapy in Quality of Life and Self-efficacy : A Clinical Waitlist Control StudyIn: Applied Psychophysiology Biofeedback, Jg. 48, 2023, Nr. 2, S. 217 – 227DOI (Open Access)
-
Electronic Patient-Reported Outcome Measures (ePROMs) Improve the Assessment of Underrated Physical and Psychological Symptom Burden among Oncological InpatientsIn: Cancers, Jg. 15, 2023, Nr. 11, 3029DOI, Online Volltext (Open Access)
-
Falling off the screening grid : Predictors for postponed utilization of psycho-oncological support in cancer patients and its implications for distress assessment and managementIn: Psycho-Oncology, Jg. 32, 2023, Nr. 11, S. 1727 – 1735DOI (Open Access)
-
Neurofeedback Treatment Affects Affective Symptoms, But Not Perceived Cognitive Impairment in Cancer Patients : Results of an Explorative Randomized Controlled TrialIn: Integrative Cancer Therapies, Jg. 22, 2023DOI, Online Volltext (Open Access)
-
Ratios of monocytes and neutrophils to lymphocytes in the blood predict benefit of CDK4/6 inhibitor treatment in metastatic breast cancerIn: Scientific Reports, Jg. 13, 2023, Nr. 1, 21262DOI, Online Volltext (Open Access)
-
Systematic symptom screening in patients with advanced cancer treated in certified oncology centers : Results of the prospective multicenter German KeSBa projectIn: Journal of Cancer Research and Clinical Oncology, Jg. 149, 2023, Nr. 11, S. 8829 – 8842DOI (Open Access)
-
The OUTREACH study: Oncologists of German university hospitals in rotation on a palliative care unit : Evaluation of attitude and competence in palliative care and hospiceIn: Journal of Cancer Research and Clinical Oncology, Jg. 149, 2023, Nr. 7, S. 2929 – 2936DOI (Open Access)
-
Development of an AI-supported exercise therapy for advanced cancer patientsIn: Current Directions in Biomedical Engineering, Jg. 8, 2022, Nr. 2, S. 169 – 172DOI (Open Access)
-
Entwicklung einer KI-gestützten Bewegungstherapie bei onkologischen Palliativpatienten : Eine PilotstudieIn: Bewegungstherapie und Gesundheitssport B&G, Jg. 38, 2022, Nr. 05, S. 208 – 215
-
PARPACT – Paramedic Palliative Care Test : Validierung eines Tests für palliatives Wissen und Selbstwirksamkeitserwartung bei Mitarbeiter*innen im RettungswesenIn: Der Schmerz, Jg. 36, 2022, Nr. 5, S. 333 – 341DOI (Open Access)
-
Palliative care outpatients in a German comprehensive cancer center : identifying indicators for early and late referralIn: BMC Palliative Care, Jg. 21, 2022, Nr. 1, 221DOI, Online Volltext (Open Access)
-
Vergleich der Eigen- und Fremderfassung der Symptomlast onkologischer Patient:innen im Rahmen einer stationären VersorgungIn: Zeitschrift für Palliativmedizin, Jg. 23, 2022, Nr. 05, S. e38 – e39
-
Web-based mindfulness and skills-based distress reduction for patients with cancer : study protocol of the multicentre, randomised, controlled confirmatory intervention trial ReductIn: BMJ Open, Jg. 12, 2022, Nr. 6, e056973DOI (Open Access)
-
A systematic review of the safety, feasibility and benefits of exercise for patients with advanced cancerIn: Cancers, Jg. 13, 2021, Nr. 17, 4478DOI, Online Volltext (Open Access)
-
Changes in fatigue, barriers, and predictors towards physical activity in advanced cancer patients over a period of 12 months : A comparative studyIn: Supportive Care in Cancer, Jg. 29, 2021, Nr. 9, S. 5127 – 5137DOI (Open Access)
-
In Reply : Letters to the Editor Symptoms During Outpatient Cancer Treatment and Options for Their Management by PD Dr. med. Mitra Tewes, PD Dr. sportwiss. Freerk Baumann, Prof. Dr. med. Martin Teufel, and Prof. Dr. med. Christoph Ostgathe in issue 17/2021In: Deutsches Ärzteblatt International, Jg. 118, 2021, Nr. 44, S. 758DOI (Open Access)
-
Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancerIn: Genome Medicine, Jg. 13, 2021, Nr. 1, 85DOI, Online Volltext (Open Access)
-
Mental health burden of german cancer patients before and after the outbreak of covid-19 : Predictors of mental health impairmentIn: International Journal of Environmental Research and Public Health = IJERPH, Jg. 18, 2021, Nr. 5, 2318DOI, Online Volltext (Open Access)
-
Screening for Palliative Care Needs : Pilot Data From German Comprehensive Cancer CentersIn: JCO Oncology Practice, Jg. 17, 2021, Nr. 10, S. e1584 – e1591
-
Symptoms during outpatient cancer treatment and options for their managementIn: Deutsches Ärzteblatt International, Jg. 118, 2021, S. 291 – 297DOI (Open Access)
-
Zusammenarbeit von Intensivmedizin und Palliativmedizin : Eine Bestandsaufnahme an den deutschen onkologischen SpitzenzentrenIn: Medizinische Klinik - Intensivmedizin und Notfallmedizin, Jg. 116, 2021, Nr. 7, S. 586 – 594DOI (Open Access)
-
[18F]-Fluorodeoxyglucose Positron Emission Tomography/CT to Assess the Early Metabolic Response in Patients with Hormone Receptor-Positive HER2-Negative Metastasized Breast Cancer Treated with Cyclin-Dependent 4/6 Kinase InhibitorsIn: Oncology Research and Treatment, Jg. 44, 2021, Nr. 7-8, S. 400 – 407DOI (Open Access)
-
Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor-positive, HER2-negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expressionIn: Cancer Medicine, Jg. 9, 2020, Nr. 13, S. 4527 – 4539DOI, Online Volltext (Open Access)
-
COVID-19-Related Fear and Health-Related Safety Behavior in Oncological PatientsIn: Frontiers in Psychology, Jg. 11, 2020, S. 1984DOI (Open Access)
-
Fatigue, barriers to physical activity and predictors for motivation to exercise in advanced Cancer patientsIn: BMC Palliative Care, Jg. 19, 2020, Nr. 1, S. 43DOI, Online Volltext (Open Access)
-
Improved survival in metastatic breast cancer : results from a 20-year study involving 1033 women treated at a single comprehensive cancer centerIn: Journal of Cancer Research and Clinical Oncology, 2020DOI (Open Access)
-
Targeted deep sequencing revealed variants in cell-free DNA of hormone receptor-positive metastatic breast cancer patientsIn: Cellular and Molecular Life Sciences - CMLS, Jg. 77, 2020, Nr. 3, S. 497 – 509DOI (Open Access)
-
The combined blood analysis of cell-free DNA and genomic DNA of circulating tumor cells reveals additive value in hormone receptor-positive, HER2-negative metastatic breast cancer patientsIn: Cancer Research, Jg. 80, 2020, Nr. 4
-
Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast CancerIn: Cancers, Jg. 11, 2019, Nr. 2, S. 238DOI, Online Volltext (Open Access)
-
Integration of palliative care into the comprehensive cancer center of Germany - Consultation hours and fellowship rotations of the specialized palliative careIn: TumorDiagnostik & Therapie, Jg. 40, 2019, Nr. 5, S. 293 – 299
-
Knowledge and Self-Efficacy Assessment of Residents and Fellows Following Palliative Care Unit Rotation : A Pilot StudyIn: American Journal of Hospice & Palliative Medicine, Jg. 36, 2019, Nr. 6, S. 492 – 499DOI, Online Volltext (Open Access)
-
Palliativdienste in den deutschen onkologischen SpitzenzentrenIn: Deutsche Medizinische Wochenschrift - DMW, Jg. 144, 2019, Nr. 23, S. E153 – E159DOI (Open Access)
-
The analysis of cell-free DNA and circulating tumor cells from one blood tube might empower treatment decisions in metastatic breast cancer patientsIn: Cancer Research, Jg. 79, 2019, Nr. Suppl. 4
-
Integration von Palliativmedizin in onkologische Spitzenzentren Deutschlands – ambulante Sprechstunden und Rotationsprogramme der spezialisierten PalliativmedizinIn: Deutsche Medizinische Wochenschrift - DMW, Jg. 143, 2018, Nr. 17, S. e139 – e145
-
Patient-Reported-Outcome-Messung (PROM) psychosozialer Belastung und Symptome für ambulante Patienten unter kurativer oder palliativer Tumortherapie : eine retrospektive Analyse eines Comprehensive Cancer CenterIn: Der Onkologe, Jg. 24, 2018, Nr. 1, S. 69 – 75
-
Predictors of outpatients’ request for palliative care service at a medical oncology clinic of a German comprehensive cancer centerIn: Supportive Care in Cancer, Jg. 26, 2018, Nr. 10, S. 3641 – 3647
-
RNA profiles of circulating tumor cells and extracellular vesicles for therapy stratification of metastatic breast cancer patientsIn: Clinical Chemistry, Jg. 64, 2018, Nr. 7, S. 1054 – 1062
-
Comparison of the PI3KCA pathway in circulating tumor cells and corresponding tumor tissue of patients with metastatic breast cancerIn: Molecular Medicine Reports, Jg. 15, 2017, Nr. 5, S. 2957 – 2968DOI (Open Access)
-
Gene expression signatures in circulating tumor cells correlate with response to therapy in metastatic breast cancerIn: Clinical Chemistry, Jg. 63, 2017, Nr. 10, S. 1585 – 1593
-
Hepatic arterial infusion chemotherapy for extensive liver metastases of breast cancer : efficacy, safety and prognostic parametersIn: Journal of Cancer Research and Clinical Oncology, Jg. 143, 2017, Nr. 10, S. 2131 – 2141
-
Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patientsIn: BMC Cancer, Jg. 16, 2016, Nr. 1, S. 522DOI (Open Access)
-
Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatmentIn: OncoTarget, Jg. 7, 2016, Nr. 27, S. 41677 – 41690DOI (Open Access)
-
Gene expression signatures in circulating tumor cells are prognostic for metastatic lesions in breast cancer patients and correlate with response to therapyIn: Cancer Research, Jg. 76, 2016, Nr. 14 Suppl., S. 502
-
Detection of disseminated tumor cells in bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancerIn: Journal of Cancer Research and Clinical Oncology, Jg. 141, 2015, Nr. 1, S. 87 – 92
-
Expression profiling of circulating tumor cells : A prognostic and predictive biomarker in metastatic breast cancerIn: Cancer Research, Jg. 75, 2015, Nr. 15 Suppl.
-
The AdnaCellector, a new fully automated selection for circulating tumor cells in blood of primary and metastatic breast cancer patientsIn: Cancer Research, Jg. 75, 2015, Nr. 15 Suppl.
-
Detection of disseminated tumor cells in the bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancerIn: Journal of Clinical Oncology (JCO), Jg. 32, 2014, Nr. 15 Suppl., S. e22032
-
Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer CenterIn: European Journal of Cancer (EJC), Jg. 49, 2013, Nr. 15, S. 3076 – 3082
-
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patientsIn: Breast Cancer Research and Treatment, Jg. 142, 2013, Nr. 1, S. 81 – 88
-
Validity of bone marker measurements for monitoring response to bisphosphonate therapy with zoledronic acid in metastatic breast cancerIn: Oncology Reports, Jg. 30, 2013, Nr. 1, S. 441 – 447
-
Aktuelle Therapiestrategien beim metastasierten MammakarzinomIn: TumorDiagnostik & Therapie, Jg. 33, 2012, Nr. 2, S. 86 – 89
-
Trends in survival of patients with metastatic breast cancerIn: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 187
-
VVTZ-Tumorprofil - First results of a preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer CenterIn: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 204 – 204
-
Comparison of PIK3CA Hot Spot Mutations in the Primary Tumor or Metastases with PIK3CA Mutations or PIK3CA Over-Expression in Circulating Tumor Cells of Metastatic Breast Cancer Patients under Sequential Palliative TherapyIn: Cancer Research, Jg. 71, 2011, Nr. Suppl. 24
-
Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patientsIn: Gynecologic Oncology, Jg. 122, 2011, Nr. 2, S. 356 – 360
-
Abstract PD02-04: Molecular Profiling of Circulating Tumor Cells in Blood of Metastatic Breast Cancer Patients Indicates Therapy Response and Provides Information on Epithelial Mesenchymal Transition and Tumor Stem Cell MetabolismIn: Cancer Research, Jg. 70, 2010, Nr. 24, S. PD02 – 04
-
Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptorIn: Journal of Clinical Oncology, Jg. 22, 2004, Nr. 1, S. 175 – 184
-
RCT to Test the Efficacy of an EEG Neurofeedback Intervention in Cancer Patients and Cancer Survivors
Deutscher Kongress für Psychosomatische Medizin und Psychotherapie, 03.-05.05.2023, Berlin,In: Zeitschrift für Psychosomatische Medizin und Psychotherapie. Göttingen: Vandenhoeck & Ruprecht, Jg. 69, 2023, Nr. 2, S. 148 – 149 -
Influence of external and self-assessment in symptom burden of cancer patients in a palliative care outpatient clinic of a Comprehensive Cancer Center
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment. Basel: Karger, Jg. 44, 2021, Nr. Supplement 2, S. 92DOI (Open Access) -
Outcome evaluation of postgraduate training in palliative medicine
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment. Basel: Karger, Jg. 44, 2021, Nr. Supplement 2, S. 27DOI (Open Access) -
Early metabolic evaluation using F-18-FDG PET/CT might help to identify patients who benefit from treatment with cdk4/6 inhibitors
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment. Basel: Karger, Jg. 43, 2020, Nr. Suppl. 4, S. 121 – 122DOI (Open Access) -
Metastatic breast cancer subgroup specific mRNA profiles of circulating tumor cells and extracellular vesicles
AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, USA,In: Cancer Research. Philadelphia: American Association for Cancer Research (AACR), Jg. 80, 2020, Nr. Suppl. 16, S. 5366DOI (Open Access) -
Palliative knowledge and self-efficacy expectation of residents before and after palliative care unit rotation - A national study project
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment. Basel: Karger, Jg. 43, 2020, Nr. Suppl. 4, S. 210DOI (Open Access) -
Barriers and motivation of physical activitiy (PA) in patients with cancer related fatigue (CRF)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,In: Oncology Research and Treatment. Basel: Karger, Jg. 42, 2019, Nr. Supplement 4: Abstracts, S. 165DOI (Open Access) -
Establishment of a workflow for analysis of mRNA and gDNA from circulating tumor cells, extracellular vesicles and cell-free DNA from the same blood sample to mirror the genomic and transcriptomic complexity in metastatic breast cancer patientsIn: Cancer Research. Philadelphia: American Association for Cancer Research (AACR), Jg. 79, 2019, Nr. Suppl. 13DOI (Open Access)
-
Use of unique molecular identifiers to gain insight about the true positive mutations in cfDNA of breast cancer patients for implementation of personalized treatmentIn: Cancer Research. Philadelphia: American Association for Cancer Research (AACR), Jg. 79, 2018, Nr. Suppl. 13DOI (Open Access)
-
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patientsIn: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 1: 31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie Berlin, 19.-22. Februar 2014: Abstracts, S. 19DOI (Open Access)
-
WTZ-Tumorprofil-A preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center : Two years experience
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin, Germany,In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 1, S. 2 – 3 -
Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patientsIn: Cancer Research. Philadelphia: American Association for Cancer Research (AACR), Jg. 73, 2013, S. PD6 – 3
-
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastastic breast cancer patients
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,In: Oncology Research and Treatment. Basel: Karger, Jg. 36, 2013, Nr. Suppl. 7, S. 157 -
Comparison of estrogen and Progesterone receptor expression on circulating Tumor cells and the Primary tumor in Patients with metastatic Breast cancer
29. Deutscher Krebskongress. Berlin 24.-27. Februar 2010,In: Onkologie. Basel: Karger, Jg. 33, 2010, Nr. Suppl. 2, S. 212 -
Evaluation of an interventional prospective study with oncological training and exercise therapy (OTT) in a health insurance care contract
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment. Basel: Karger, Jg. 44, 2021, Nr. Supplement 2, S. 280DOI (Open Access)